NCT05898594
- Conditions
- Lung Cancer, Lung Carcinoma, Lung Diseases, +6 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
Clinical trial condition
Lung Carcinoma
Explore clinical trials studying Lung Carcinoma. Study availability and eligibility vary by location and protocol.
78 public trials
29 recruiting studies
Lung Carcinoma trial results
NCT03582124
- Conditions
- Lung Carcinoma, Lung Diseases, Lung Neoplasms, +9 more
- Locations
-
- Stanford University, School of Medicine Palo Alto, California, United States
NCT05775939
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Carcinoma, +13 more
- Locations
-
- Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
NCT03422302
- Conditions
- Lung Carcinoma, Lung Diseases, Lung Neoplasms, +7 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Recruiting
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
NCT07291414
- Conditions
- Breast Carcinoma, Breast Diseases, Breast Neoplasms, +30 more
- Locations
-
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
NCT06645808
- Conditions
- Astrocytoma, Bladder Carcinoma, Breast Cancer, +66 more
- Locations
-
- University Medical Center Groningen (UMCG) Groningen, Provincie Groningen, Netherlands
Recruiting
Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
NCT05978128
- Conditions
- Breast Carcinoma, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
Recruiting
Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer
NCT05384769
- Conditions
- Lung Carcinoma, Lung Diseases, Lung Neoplasms, +5 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Recruiting
68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.
NCT06608160
- Conditions
- Immunotherapy, Lung Carcinoma, Lung Diseases, +7 more
- Locations
-
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
Enrolling by Invitation
Evaluating the Impact of Centralized Interventions on Lung Cancer Screening Adherence in Community Settings, ACCELL Trial
NCT06324110
- Conditions
- Lung Carcinoma, Lung Diseases, Lung Neoplasms, +5 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States